We provide CLIA/CAP next-generation sequencing (NGS) services and testing solutions to help develop and deliver personalized and precision diagnostics.
Our services include
Co-development Services
Our breakthrough NGS technology, diagnostic development expertise and collaborative culture makes us ideal partners for life science companies developing new, targeted therapies that require a companion diagnostic.